Josh Gottheimer (D-NJ)
Improving Medicaid Precision and Cancer Test Act of 2025
A Democratic bill with 1 Republican cosponsor · See all 3 cosponsors
Last activity — Referred to the House Committee on Energy and Commerce.
In committee
Introduced and handed to a committee in the chamber it started in.
The committee holds it, and most bills are never heard from again. A hearing or a committee vote would be news; silence is the usual outcome, and it kills the bill without anyone voting against it.
Its path through Congress
- Introduced
- In Committee
What this bill would do
This bill, known as the ``Improving Medicaid Precision and Cancer Test Act of 2025'', aims to amend title XIX of the Social Security Act. The primary goal is to require the Medicaid program to cover lung cancer biomarker testing. These changes involve amending specific sections of the Social Security Act, including sections 1902 and 1905. The coverage requirement is set to begin on January 1, 2027.
Yes· 3 of 9
- Scored +5
Would households on low incomes be better off under this?
The bill provides required coverage for lung cancer biomarker testing for Medicaid participants.
- Scored +5
Does this put more money into Medicaid, the health coverage for people on low incomes?
The bill mandates that Medicaid cover lung cancer biomarker testing starting January 1, 2027.
- Scored +5
Does this make health care easier to get in general?
The bill expands access to specialized lung cancer biomarker testing for Medicaid recipients.
The opposite
No question was scored the opposite.
Who it would affect, and how
Potential Positive Impacts for People
- Required Medicaid Coverage: The bill amends the Social Security Act to include lung cancer biomarker testing as a covered service under the Medicaid program (Section 2(a)). This ensures that individuals relying on Medicaid can access these specific tests.
Potential Negative Impacts for People
- No negative impacts are explicitly mentioned in the provided text.
Groups and Interests Ranking
Every group the model scored this bill for, from -10 to +10. Tap or hover a score for the reason it gave.
- Demographic And Interest Groups
- Would households on low incomes be better off under this? — The bill provides required coverage for lung cancer biomarker testing for Medicaid participants. Would Black Americans be better off under this? — Expanding Medicaid coverage for cancer testing helps address health disparities for many Black Americans. Would Asian Americans be better off under this? — The bill improves medical coverage for Asian Americans who rely on the Medicaid program. Would Hispanic Americans be better off under this? — The mandate for biomarker testing coverage provides a benefit to Hispanic Americans enrolled in Medicaid. Would Native Americans be better off under this? — The bill expands essential health services for Native Americans participating in Medicaid. Would people over 65 be better off under this? — The bill expands medical coverage for cancer testing which benefits many elderly Medicaid recipients. Would white Americans be better off under this? — The bill provides increased medical coverage through the Medicaid program for white Americans.
- Healthcare
- Does this make health care easier to get in general? — The bill expands access to specialized lung cancer biomarker testing for Medicaid recipients. Does this put more money into Medicaid, the health coverage for people on low incomes? — The bill mandates that Medicaid cover lung cancer biomarker testing starting January 1, 2027.
- 2/3/2026
- 1 Cosponsor added.
- 12/15/2025
- 1 Cosponsor added.
- 11/28/2025
- Referred to the House Committee on Energy and Commerce.
- 1 Cosponsor added.
- Introduced in House
Adelita GrijalvaDemocrat · Arizona
John RutherfordRepublican · Florida
Eric SwalwellDemocrat · California